HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress.

Abstract
Adenylate kinases (AKs) are phosphotransferases that regulate the cellular adenine nucleotide composition and play a critical role in the energy homeostasis of all tissues. The AK2 isoenzyme is expressed in the mitochondrial intermembrane space and is mutated in reticular dysgenesis (RD), a rare form of severe combined immunodeficiency (SCID) in humans. RD is characterized by a maturation arrest in the myeloid and lymphoid lineages, leading to early onset, recurrent, and overwhelming infections. To gain insight into the pathophysiology of RD, we studied the effects of AK2 deficiency using the zebrafish model and induced pluripotent stem cells (iPSCs) derived from fibroblasts of an RD patient. In zebrafish, Ak2 deficiency affected hematopoietic stem and progenitor cell (HSPC) development with increased oxidative stress and apoptosis. AK2-deficient iPSCs recapitulated the characteristic myeloid maturation arrest at the promyelocyte stage and demonstrated an increased AMP/ADP ratio, indicative of an energy-depleted adenine nucleotide profile. Antioxidant treatment rescued the hematopoietic phenotypes in vivo in ak2 mutant zebrafish and restored differentiation of AK2-deficient iPSCs into mature granulocytes. Our results link hematopoietic cell fate in AK2 deficiency to cellular energy depletion and increased oxidative stress. This points to the potential use of antioxidants as a supportive therapeutic modality for patients with RD.
AuthorsAlberto Rissone, Katja Gabriele Weinacht, Giancarlo la Marca, Kevin Bishop, Elisa Giocaliere, Jayashree Jagadeesh, Kerstin Felgentreff, Kerry Dobbs, Waleed Al-Herz, Marypat Jones, Settara Chandrasekharappa, Martha Kirby, Stephen Wincovitch, Karen Lyn Simon, Yuval Itan, Alex DeVine, Thorsten Schlaeger, Axel Schambach, Raman Sood, Luigi D Notarangelo, Fabio Candotti
JournalThe Journal of experimental medicine (J Exp Med) Vol. 212 Issue 8 Pg. 1185-202 (Jul 27 2015) ISSN: 1540-9538 [Electronic] United States
PMID26150473 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Azo Compounds
  • DNA Primers
  • Naphthalenes
  • Sudan Black B
  • Adenylate Kinase
  • adenylate kinase 2
  • Acridine Orange
Topics
  • Acridine Orange
  • Adenylate Kinase (deficiency, metabolism)
  • Animals
  • Antioxidants (pharmacology)
  • Apoptosis (physiology)
  • Azo Compounds
  • Base Sequence
  • Cell Differentiation (drug effects)
  • Computational Biology
  • DNA Primers (genetics)
  • Hematopoietic Stem Cells (physiology)
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Leukopenia (enzymology, physiopathology)
  • Molecular Sequence Data
  • Naphthalenes
  • Oxidative Stress (physiology)
  • Pluripotent Stem Cells (physiology)
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Analysis, DNA
  • Severe Combined Immunodeficiency (enzymology, physiopathology)
  • Zebrafish

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: